Nanotechnology

Implementing the innovative project for creating a production of next-generation medical equipment capable of nanofiltration of blood plasma components — down to individual protein molecules — will make it possible to solve a number of urgent problems standing in the way of building an innovative system of medical care on a national scale.

Track nano-membranes Specialists from TRACKPORE TECHNOLOGIES JSC and JINR, in cooperation with the A. V. Shubnikov Crystallography Institute of the Russian Academy of Sciences, have developed a technology that makes it possible to produce track nano-membranes with pore diameters of 20 to 100 nm having pre-set unique characteristics (pore shape and size, specified surface properties). Such nano-dimensions are obtained by bombarding a polymer film with ions of heavy inert gases accelerated in a cyclotron. The nano-trails left by the ions in the film (tracks) are selectively converted into pores with the specified characteristics using ultraviolet irradiation and special chemical etching. They will make it possible not only to filter formed elements, but also to separate plasma into its constituents — for example, to isolate large protein complexes that form during immune reactions, and to return the albumin fraction to the bloodstream. This will make it possible, for example, to treat people with autoimmune diseases. To produce nano-filters, JINR and "TRACKPORE TECHNOLOGIES" will build a new-type accelerator.

Track nano-membranes

Specialists from TRACKPORE TECHNOLOGIES JSC and JINR, in cooperation with the A. V. Shubnikov Crystallography Institute of the Russian Academy of Sciences, have developed a technology that makes it possible to produce track nano-membranes with pore diameters of 20 to 100 nm having pre-set unique characteristics (pore shape and size, specified surface properties). Such nano-dimensions are obtained by bombarding a polymer film with ions of heavy inert gases accelerated in a cyclotron. The nano-trails left by the ions in the film (tracks) are selectively converted into pores with the specified characteristics using ultraviolet irradiation and special chemical etching. They will make it possible not only to filter formed elements, but also to separate plasma into its constituents — for example, to isolate large protein complexes that form during immune reactions, and to return the albumin fraction to the bloodstream. This will make it possible, for example, to treat people with autoimmune diseases. To produce nano-filters, JINR and "TRACKPORE TECHNOLOGIES" will build a new-type accelerator.

In partnership with ROSNANO A modern high-tech production of nano-filters is currently being created within the framework of a project implemented by the company "TRACKPORE TECHNOLOGIES" in partnership with ROSNANO. At present, the project has no counterparts in Russia in terms of scale and technical equipment. Mass production of this unique medical equipment will begin in 2016, and just one year later the BETA sci-tech complex will reach its designed production capacity of devices and plasma filters for performing 800,000 cascade plasma filtration procedures per year. The expensive fiber filters currently used for cascade plasmapheresis are manufactured in countries such as Japan, Germany, and Italy. However, the domestic technology for producing track nano-filters and devices for performing the procedure has no worldwide counterparts. Implementing domestic nanotechnology will help reduce the cost of medical equipment for hemocorrection by an order of magnitude and make it accessible to the broadest segments of the population.

In partnership with ROSNANO

A modern high-tech production of nano-filters is currently being created within the framework of a project implemented by the company "TRACKPORE TECHNOLOGIES" in partnership with ROSNANO. At present, the project has no counterparts in Russia in terms of scale and technical equipment. Mass production of this unique medical equipment will begin in 2016, and just one year later the BETA sci-tech complex will reach its designed production capacity of devices and plasma filters for performing 800,000 cascade plasma filtration procedures per year.

The expensive fiber filters currently used for cascade plasmapheresis are manufactured in countries such as Japan, Germany, and Italy. However, the domestic technology for producing track nano-filters and devices for performing the procedure has no worldwide counterparts. Implementing domestic nanotechnology will help reduce the cost of medical equipment for hemocorrection by an order of magnitude and make it accessible to the broadest segments of the population.